Fintel on MSN2d
Wells Fargo Upgrades Regulus Therapeutics (RGLS)Fintel reports that on March 27, 2025, Wells Fargo upgraded their outlook for Regulus Therapeutics (NasdaqCM:RGLS) from Equal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback